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Differential gene expression is the primary determinant of numerous biological processes such as cell 
differentiation, proliferation, organogenesis, tumor progression and apoptosis. In that context, 
regulatory proteins play pivotal roles and determine cell fate in all physiological conditions of 
differentiation, development and disease. As these regulatory proteins are present in extremely small 
amount in cells, their isolation and identification from tissues is impracticable. These regulatory 
proteins bind to the target sites (DNA elements) located in the promoter, enhancer and other regulatory 
region of the genome. These target sites control the developmental expression of genes. In the present 
paper we have isolated and characterized one novel target site (GTGTT) which is developmentally 
expressed during chick heart development.  
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In order for the cell to utilize the information contained 
within its genome, individual gene, each of which represents 
a single unit of information, has to be expressed in a 
coordinated manner (Wyeth and Albin, 2004). Co-ordination 
of gene expression determines the cellular transcriptome, 
which in turn specifies the nature of the proteomes and 
defines the cellular function. Control of gene transcription 
is one of the major regulatory mechanisms operative in a 
particular cell type. Transcription regulation in eukaryotes 
is a coordinated process and requires the concerted 
functions of multiple proteins or transcription factors (Gross 
and Oelgeschläger, 2006). 
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complex at the right time and at the right promoter is a 
prerequisite to executing the correct programs of mRNA 
synthesis. This involves the interplay of many gene 9.5 
regulatory DNA elements located in the promoter enhancer 
regions of various tissue and developmental stage 
restricted genes (Bryan and Tjian, 2000).  
The expression pattern of numerous genes changes 
dynamically depending on the developmental stage and 
the differentiation state of the cell. Transcription factors 
regulate cellular events at the gene expression level by 
communicating signals to the general transcription 
machinery that forms a preinitiation complex (PIC) at 
class II core promoters. Recent data strongly suggests 
that preinitiation complex formation at distinct promoters 
reflect the spatiotemporal profile of gene expression in 
multicellular organisms and that core promoter recog-
nition by distinct factors is an additional level of 
transcriptional regulation (Hochheimer and Tjian, 2003). 
Until recently, the general transcription machinery that 
makes up the PIC was thought to be largely invariant. 
However, during recent years, several homologues of 
basal transcription factors including additional member of 
TATA box protein (TBP) family such as TBP-related  factors  
 




(TRFs-TRF1, TRF2 and TRF3) have been identified in 
metazoan organisms. In addition, a large number of 
tissue-specific transcription factors have been described 
that control expression of cell-type specific genes and 
most of these are enhancer-binding transcription factors 
(Boyle et al., 2006).  
One of the key questions in gene regulation is how 
specific sets of genes are selected for expression during 
cell growth, differentiation, apoptosis or in response to 
environmental cues. Gene expression program during 
embryonic development is highly orchestrated and precise 
(Yang et al., 2007). Therefore, how the array of distinct 
developmental programs is established by a genome of 
fixed size remains a question yet to be answered. 
Nonetheless, formation of a pre initiation complex at the 
right time and at the right promoter is presumably the 
mechanism by which such a diverse developmental 
program is executed. Furthermore, initiation of specific 
set of genes and their transcription at the right level is 
directed by an array of cis-regulatory DNA element and 
their cognate gene specific transcription factors (Corry 
and Underhill, 2005). Although eukaryotic gene expression 
is initiated by the transcription apparatus assembled at 
the core promoter region (TATA sequence/ downstream 
promoter elements), the extent of transcription is 
controlled by the gene specific transcription factors 
operating at the upstream regulatory regions of the 
promoter. The gene specific transcription factors (GSTFs) 
constitute the largest and the most divergent class of 
DNA-binding proteins (Grondin et al., 2007). Gene 
specific transcription factors mediate their effects by 
diverse mechanisms such as tissue-restricted activity, 
existence of different isoforms, and formation of functional 
complex by hetero and homo dimerization. They are 
characterized by their specific binding to distinct DNA 
elements found in the regulatory regions of different genes. 
DNA sequencing data derived from the human genome 
suggests that the total number of genes is ~ 30,000 to 
40,000, only fractions of which have yet been annotated. 
As more and more genomes are sequenced, organisms 
are increasingly represented by a list of genes although 
there is little knowledge as to how these expressions are 
coordinated (Venter et al., 2001). Thus the major 
challenge of the post-sequencing era is to understand 
gene regulation in a global scale and to assign the 
function to tens of thousands of genes. Integrative 
approaches such as computational analysis of the gene 
regulatory regions, their expression profiling and functional 
characterization are required for gene discovery and 
pathway elucidation (Saurabh and Martin, 2002). In this 
context, subsets of genes which encode nucleic acid 
binding proteins (NBPs) are most important to analyze for 
their function. It is estimated that 1.5% of the human 
genome encodes proteins.  The remaining of the genome 
contains various regulatory signals that control their 





These regulatory signals are typically protein-target sites 
(sequence motifs), which are too short and degenerate 
having variability in nucleotide preference at certain 
positions. Nonetheless, there is much evidence that these 
regulatory elements occur in clusters especially for 
regulating transcription (such as enhancers/silencers 
containing multiple cis elements spread over a few 
hundred base pairs). It is believed that such clusters of 
signals are individually weak but collectively strong 
(Birnbaum et al., 2001). Organisms have devoted a 
significant fraction of their DNA to encrypt cis-regulatory 
programs that control and coordinate gene expression at 
the level of transcription. The output(s) of the cis-
regulatory programs depend on the cellular context and 
extra-cellular inputs. Typically, an external stimulus 
activates a signal transduction pathway which leads to 
the modification of the activities of several transcription 
factors which in turn target enhancers/regulatory regions 
of certain genes, effecting their expression (Ian, 2007). 
DNA element targeted by sequence specific binding 
proteins are small, of variable length (4 bp and above) 
and often show limited degeneracy at various nucleotide 
positions, therefore making it difficult to be identified in 
the background of the entire genome, especially in 
metazoan cell. It is thus expected that efficient identi-
fication of novel regulatory target sites and their cognate 
factors will definitely contribute to the comprehensive 
understanding of gene regulation. 
Embryonic development and organogenesis is a highly 
orchestrated process involving precise and integrated 
control of gene expression (Barker, 2007). It involves an 
enormously complex gene regulatory network. Lineage 
specification and differentiation of various cell types 
underlie the basic mechanism of organogenesis (Ahuja et 
al., 2007). Since a functional circulatory system is essential 
for the progress of embryogenesis, heart formation is one 
of the first signs of organogenesis within the developing 
embryo and cardiac myocytes are amongst the earliest 
differentiated cell types. This process is conserved from 
flies to man (Nemer and Nemer, 2001). During the recent 
years, heart development has come up as a paradigm of 
cell differentiation and organogenesis (Keller et al., 
2007).   
In the present study, we have identified one novel 
developmentally regulated target sites isolated from 
embryonic chick heart by using methodology reported by 
Sindhu et al. (2004). We have previously described an 
efficient method of isolation of a library of DNA elements 
targeted by sequence specific proteins.  
 
 











synthesized from Genosys, USA. Polymerase chain reaction (PCR) 
was done using KlenTaq DNA polymerase. All chemicals were 
purchased from Sigma Aldrich unless mentioned otherwise.  
 
 
Screening of “developmentally regulated target sites 
 
Synthetic oligonucleotides used for the construction of a pool of 
random decanucleotide sequences was as described by Nallur et 
al. (1996). Single stranded oligonucleotide was amplified by PCR 
using primers encompassing the terminal sequences (M1 and M2, 
primer synthesized from pBluescript vector). The PCR product was 
then digested with HincII and SpeI and cloned into pBluescipt 
plasmid vector (+/-) digested with the same enzymes. The 
frequency of recombination was checked by PCR amplification of 
randomly picked up bacterial colonies using the same primer. More 
than eighty percent of transformants contained the recombinant 
plasmids and were pooled in batches. The cognate binding sites 
were then selected from the pre pool by four consecutive steps of 
gel-mobility shift followed by PCR. Plasmid DNA isolated from each 
pool of recombinants was amplified and 1 ng of amplified DNA was 
used for binding with 40 µg nuclear protein prepared from 12 day 
old chick embryonic heart. The reaction was then resolved on 8% 
acrylamide gel and the entire lane starting from 1 cm above the 
unbound oligonucleotide (identified by ethidium bromide staining) to 
0.5 cm below the well was excised, crushed into small pieces and 
eluted overnight in a buffer containing 500 mM ammonium acetate, 
10 mM magnesium chloride (MgCl2), 1 mM ethylenediaminete-
traacetic (EDTA), 0.1% sodium dodecyl sulfate (SDS). The eluted 
DNA was then precipitated using 100 ng of poly dI-dC as a carrier 
and amplified by a second set of internal primer pairs obtained from 
the pBluescript vector. The selection process was then repeated 
followed by the amplification with a further internal primer pair. Use 
of sequentially internal primer pairs during selection-amplification 
cycles helped in obtaining cleaner PCR products after each rounds 
of selection and also increases the kinetics of interaction between 
the target sites and the proteins. After four rounds of selection, the 
eluted material was finally amplified by the innermost primerpairs 
and cloned into the pBluescript vector at the Hinc II and SpeI sites 
as before (for the construction of the pre pool) (Sindhu et al., 2004). 
The recombinants thus obtained were then pooled and saved as 





The nucleotide sequencing of selected target sites were manually 
done using sequencing kit from Epicenter Biotechnologies, USA. 
The samples were run on 6% acrylamide gel containing 6 M urea. 
 
 
Preparation of nuclear extracts from chick embryos 
 
12-days-old chick embryos were taken for nuclear extract preparation. 
All steps were conducted at 4°C. Brain, heart, liver and skeletal 
tissues were taken out from chick embryo and added to the 
prechilled hand homogenizer. One ml of buffer A (20 mM Hepes 
(Sigma), 20% glycerol (Qualigen), 10 mM NaCl (Sigma), 1.5 mM 
MgCl2 (Sigma), 0.2 mM EDTA (Sigma) 0.1% triton-X100 (Sigma), 
100 mM phenylmethylsulphonyl fluoride (PMSF) (Sigma), 1 mM 
dithiothreitol (DTT) (Sigma), 10 mg/ml Leupeptin (Sigma), 10 mg/ml 
Aprotenin (Sigma)) was added in each homogenizer having 
individual tissue. The tissues were homogenized in ice. The 
homogenates were centrifuged at 2500 rpm at 4°C for 15 min. 
Supernatants were discarded, pellets were then resuspended in 
300 - 500 l  of  buffer  B  (20 mM  Hepes , 20%  glycerol,  500 mM  




NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.1% triton-X, 100 mM PMSF, 
1 mM DTT, 10 mg/ml Leupeptin, 10 mg/ml Aprotenin) and incubated in 
ice for 60 min with intermittent tapping (at every 10 min interval). 
The homogenates were then centrifuged at 13,000 rpm at 4°C for 
15 min. The supernatants were aliquoted and snap freezed at -
70°C. Bradford (1976) method was used to estimate the protein 
concentration in the samples.  
 
 
Gel shift assay  
 
Protein-DNA Binding reactions were carried out in 40 µl volume. 
Binding reactions contain (20 mM HEPES pH 7.9, 5% glycerol, 60 
mM NaCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM DTT), 4 µl (20 µg) 
nuclear extract, 1 µg poly dIdC and 32P- labeled probe (40,000 
cpm). All the components were mixed thoroughly and incubated in 
ice for 30 - 45 min. For competition, 100 fold molar excess of cold 
(unlabeled) DNA (self or nonself) was added to the binding reaction 
prior to the addition of the labeled probe. Cold competitor was first 
added, incubated in ice for 10 min and then radiolabeled probe was 
added in the reaction tube. DNA-protein complexes were separated 




DNAse I foot printing assay 
 
Bovine pancreatic deoxyribonuclease I (DNAse I; Sigma) was 
stored as a 30 unit/µl solution in 5 mM sodium acetate (pH 4.0), 1 
mM CaCl2 and 50% glycerol. DNA was amplified with pBluescript 
specific T3 and T7 primers. DNA was digested with PauI enzyme, 
electroeluted and then klenow labeled. The stock solutions of 
DNAse I were kept at -20˚C and freshly diluted to the desired 
concentration immediately prior to use. Foot printing experiments 
were performed in 40 l reaction volume. 40 – 50 g of 12-day-old 
chick nuclear heart and liver extracts were incubated with the 
labeled DNA fragments (Klenow labeled) for 60 min. Poly dIdC was 
added to avoid nonspecific binding. After 60 min of incubation at 
4°C, digestion was initiated by the addition of DNAse I solution 
whose concentration was adjusted to yield a final enzyme 
concentration of about 0.01 unit/ml in the reaction mixture. For 
DNAse I activity, cofactor solution containing 10 mM MgCl2, 5 mM 
CaCl2 was added to the reaction mix. DNAse I treatment was given 
at 37°C. After the required period of time (varies from 30 - 70 s), the 
reaction was stopped by adding stop buffer (1% SDS, 200 mM 
NaCl, 20 mM EDTA). Samples were then phenol-chlorophorm 
extracted and precipitated by 0.1 vol of 1 M NaCl and 2.5 vol of 
absolute alcohol. Samples were resuspended in loading dye 
containing 95% formamide solution, 0.1 mM EDTA and tracking 
dyes (bromophenol blue and xylene cyanol.), heat denatured at 
95˚C for 5 min and electrophoresd in 6% acrylamide gel containing 
5 M urea.   
 
 
South western blotting 
 
South western blotting was used to detect the DNA-protein 
interaction. 12-days-old chick embryonic heart, liver and brain 
nuclear extracts were prepared and quantitated according to the 
Bradford (1976). Bovine serum albumin (BSA) was used as the 
standard. Polyacrylamide gel electrophoresis under denaturing 
condition (in the presence of 0.1% SDS) was performed according 
to the method of Laemmili, (1970). 40 µg of nuclear extracts from 
12-day-old chick embryonic brain, liver and heart were loaded with 
equal amount of loading dye (5% SDS, 5 mM Tris.Cl pH 6.8, 2M 
DTT, 20%  glycerol)  onto  the  gel. The  proteins  were  stacked  at  
 






Figure 1. A schematic presentation of the strategy for 
isolation and characterization of novel developmentally 




pH 6.8 in stacking gel containing 4% acrylamide (Sigma), 0.106% 
N, N’ methylene bis acrylamide (Sigma), 0.125 M Tris.Cl, pH 6.8, 
0.01% TEMED (Amresco) and 0.1% ammonium per sulphate 
(Amresco). The resolving gel was made of 12% acrylamide, 0.33% 
N, N’ methylene bis acrylamide, 0.375 M Tris Cl. PH 8.8, 0.01% 
TEMED and 0.1% ammonium per sulphate. The protein samples 
were electrophresed in running buffer consisting of 0.025 M tris 
base, 0.192 M glycine, pH 8.3 and 0.1% SDS. After complete run, 
the gel was transferred to nitrocellulose (Hybond R+) membrane for 
16 h in transfer buffer containing 0.025 M tris base, 0.192 M glycine 
(Merck), pH 8.3 and 15% methanol (Qualigen). After complete 
transfer, the membrane was removed from transfer apparatus and 
blocked by blotto (50 mM Tris.Cl pH 7.5, 50 mM NaCl, 1 mM EDTA, 





agitation. Blot was then washed thrice in washing solution (50 mM 
Tris.Cl pH 7.5, 50 mM NaCl, 1 mM EDTA, and 1 mM DTT). After 
that, membrane was blocked in binding buffer (10mM Tris.Cl, pH 
7.5, 25 mM NaCl, 10 mM MgCl2, 5 mM EDTA, 1 mM DTT) with 200 
fold molar excess of poly dIdC for 2 h at 4°C. After poly dIdC 
incubation, membrane was soaked in binding buffer for 8 h and 
then soaked in binding buffer containing 106 cpm/ml radioactive 
probe for overnight at 4°C. Membrane was finally washed four 
times in binding buffer (each wash for 8 min at room temperature). 
After washing, the membrane was air-dried and exposed to x-ray 





Screening of “developmentally regulated target 
sites” 
 
During the past decade, number of laboratories indepen-
dently developed methods for the isolation of transcription 
factor binding sites from an unbiased pool of randomized 
oligonucleotides. However, majority of these studies 
involve purified recombinant protein, ensuring its efficient 
binding and selection of the cognate target sites. None-
theless, methodologies for the isolation of novel target 
sites by using total nuclear protein have also been 
described (Nallur et al., 1996). However, such approaches 
are presumably of limited efficiency due to sub-optimum 
interaction between multiple transcription factors (and 
other sequence specific DNA binding proteins) with their 
cognate binding sites present in the milieu (1 X 106 
variants or more) sequences. Such constraint is further 
compounded for less abundant proteins. Our laboratory 
had developed an efficient method of isolating a large 
variety of DNA sequences targeted by sequence specific 
DNA binding proteins.  
Briefly, a pre-pool of about 1.5 X105 of randomized 
decanucleotide sequences were constructed in the 
pBluescript plasmid vector. Independent pool (1 - 1.5 X 
104) of sequences were selected by four consecutive 
rounds of gel-mobility shift and PCR by using embryonic 
chick heart nuclear extract. After four consecutive rounds 
of selection, we further cloned the embryonic heart 
enriched target sites in the same vector and prepared the 
“Catalogue of developmentally regulated target sites.” 
Figure 1 shows a schematic presentation of the strategy 
adopted for isolation and characterization of novel 
regulatory target site (ATAGTGTGTT) from embryonic 
chick heart.  
 
 
Sequence characterization of regulatory target sites 
isolated from embryonic chick heart 
 
We randomly picked up around 200 recombinant clones 
harboring protein target sites and their nucleotide 
sequences were determined by conventional method see. 
Figure 2 shows the sequencing profile of five representative  
 






Figure 2. Sequencing of recombinant clones. Cyclic sequencing of pBluescript multiple cloning sites 
harboring 10 nucleotide long randomized sequences were performed by dideoxy method. Around 200 
recombinant clones were sequenced. Sequencing profile of five representative clones is shown. 
Decanucleotide sequence is marked by bracket. Four lanes are marked as G, A, T, C.  ATAGTGGTGTT 




clones harboring the randomized sequence. Following 
sequencing, identity of each sequence was established 
by comparing with the existing transcription factor binding 
site database “TRANSFAC” (http://www.gene-regulation. 
com). Following such comparison, one hundred sequences 
were “known” (previously reported in the context of 
various promoters expressing in both cardiac and non-
cardiac tissues). The remaining ninety sequences were 
novel (not listed in TARNSFAC database).  Table 1 
represents a complete list of such analysis.  
 
 
Characterization of novel target sites by foot printing 
assay 
 
After establishing the identity of novel binding sequences, 
we further characterized them by determining the protein 
binding sequence. It may be noted that the randomized 
sequences originally used for selection were ten-
nucleotide long. However, that does not necessarily 
mean that their cognate proteins targeted the entire 
sequence. The lengths of regulatory target sites are 
variable (GATA, CANNTG (E-box), TGACTCA (AP-1), 
TTATTTTTA (MEF2)). It was thus expected that many of 
the target sites we had selected were smaller than ten 
base pairs (the length used for their selection). We 
therefore randomly picked up some of those sequences 
and identified the exact protein binding sequences by 
DNAse I foot printing analysis using nuclear extracts from 
12-day-old chick embryonic heart and liver. DNAse I 
protected sequences ranged from pentanucleotide, 
heptanucleotide, entire decanucleotide, a bipartite tetra-
nucleotide sequence with a two nucleotide spacer, or 
entire decanucleotide sequence along with part of the 
vector sequences (data not shown). Figure 3 represents 
the foot print analysis of one such novel target site 
ATAGTGTGTT (CLONE No. 2 in Table 1). Pentanucleotide 
region “GTGTT” was found to be protected by the protein 
extracted from chick embryonic tissues. 
In the present study we extensively characterized 
binding activity of one such novel target site “ATAGTG 
TGTT” by experimental as well as insilio parameters. 
 




Table 1. Compilation of nucleotide sequences of protein 
target sites. Based on the TRANSFAC database search, each 
binding sites were classified as known or novel (-). 
 
Clones Nucleotide sequence Target sites 
Clone 1 GAATCGGTGC GFI-1 
Clone 2 ATAGTGTGTT - 
Clone 3 GTACAGTGTT - 
Clone 4 GTATCCTAGT GATA 
Clone 5 ATGATTGATG AP-1 
Clone 6 TAAGAGTCG - 
Clone 7 TTAGTGTGTC - 
Clone 8 TGAGAGTGTC - 
Clone 9 TACGGGGAGG IK2 
Clone 10 ATAGTGTGTT - 
Clone 11 AATTCAATG OCT-1 
Clone 12 TGAACTCTTG - 
Clone 13 GTACCTAAGC DELTAF-1 
Clone 14 GTCGGTAAGC - 
Clone 15 TACGGCTGCG AP-4 
Clone 16 GTATCTGCT GATA 
Clone 17 CACTAGGTCG - 
Clone 18 ATACTTTTT - 
Clone 19 TGAGGAGTTA - 
Clone 20 TACGGGGAGG MZF 
Clone 21 CATTGGCCC NF-1 
Clone 22 ATCTTGGGCT - 
Clone 23 TAACTACATA - 
Clone 24 TGTAATTGG CAAT 
Clone 25 AGGCACGTGC MYO-D , USF 
Clone 26 TTACATTCCG OCT-I 
Clone 27 GGTAGTATGG - 
Clone 28 GCTAAGTTGT - 
Clone 29 TGTAGCGGGG vMZF 
Clone 30 GAGGGCAATCG IK-1,2 
Clone 31 CATTGGCCC CAAT, S8 
Clone 32 TAAGAGTCG - 
Clone 33 TCTTAATCCT NKx-2.5 
Clone 34 GTGTCCAGG - 
Clone 35 TTACATTCCG VBP 
Clone 36 TGTAATTG NF-1, CAAT 
Clone 37 TCTTGTCG - 
Clone 38 AAAATTCTCT - 
Clone 39 TGTTGGCTCC NF-1 
Clone 40 TGCATACTGC OCT-1 
Clone 41 AGGCACGTGC ARNT-1 
Clone 42 CCTCTGGTGG - 
Clone 43 CTGCATTTGC - 
Clone 44 CCTCTGGTGG - 
Clone 45 CTAAGTCTGT - 
Clone 46 GTCTGTGCGTG AHRARNT 
Clone 47 ATGGGCGTT - 





Table 1. Contd. 
 
Clones Nucleotide sequence Target sites 
Clone 49 GGACAAGCGT - 
Clone 50 CTGTTTCGGC - 
Clone 51 TTTTCTTTCA NF-AT 
Clone 52 CTACAGTGTC - 
Clone 53 AGTTGCAGCT AP-4 
Clone 54 TTTTCTCTCG - 
Clone 55 TTTTCTTTC NF-AT 
Clone 56 TAGGCGCCGC - 
Clone 57 TAGTCTCACT - 
Clone 58 CAAGGTTGTA - 
Clone 59 TGAAGTATCC GATA 
Clone 60 TACTCTCACT - 
Clone 61 TTATTGGGT NKX-2.5 
Clone 62 TGTTAGGGT CAAT, NFY, S8 
Clone 63 TCAGGTGTAG E47, MYOD 
Clone 64 ATTCGTTGGT - 
Clone 65 TTGGCCCTGG NF-1 
Clone 67 GGGTGATTT GFI-1 , PADS 
Clone 68 CTCCCTATTT IK2 
Clone 69 TTAGTTTGC - 
Clone 70 TTAGTCTGC - 
Clone 71 TGAAGTATCC GATA 
Clone 72 TGTGTGTATC GATA, 
Clone 73 TTCAGTTATC LMO2COM 
Clone 74 GAAGCCATTA CAAT, S8 
Clone 75 GAAGACATTA - 
Clone 76 CTCCCTATTT IK2 
Clone 77 GCATATGGCA OCT-1 
Clone 78 CTGCTTGCGC - 
Clone 79 ATCATACGT TCF -II 
Clone 80 AGACCAACCC - 
Clone 81 GGGTGATTTA GFI-1 
Clone 82 CTTCCTCTAG NRF-2 
Clone 83 GAACCCAAGT - 
Clone 84 GAACCCATTA S8 
Clone  85 GAAGCCATTA CAAT, S8 
Clone 86 TGGCAGAAC NF-1 
Clone 87 ATGTGTTGGG - 
Clone 88 AGTTCTCAT - 
Clone 89 TGGCAGTAC NF-1 
Clone 90 CGGAACTCG - 
Clone 91 GATCACCGGG - 
Clone 92 CGGAACTCG - 
Clone 93 GTCATCACGC AP-1, TCF-II 
Clone 94 ATTAAGGGGT - 
Clone 95 CATGGGGCCG - 
Clone 96 CTGGCTTCAG NF-1 
Clone 97 GGTACGGTT v & c myb 
Clone 98 TTTCATAGAG TCF 






Table 1. Contd. 
 
Clones Nucleotide sequence Target sites 
Clone 100 CGTCCTACA - 
Clone 101 GTGATGTGTG v-PADs 
Clone 102 AGTTAGGAC - 
Clone 103 TGCCGAGAGC - 
Clone 104 GGTCAAGTCT RORA1, ER 
Clone 105 ATGATTGATG AP-1, PBX-1 
Clone 106 GGCCGAGAGC - 
Clone 107 TAAGAGCTAG - 
Clone 108 TAAGAGCTTG - 
Clone 109 ATGATTGATG CDPCK3H, TCF-II 
Clone 110 TGGCCCACAC NF-1 
Clone 111 TACGACGAGG - 
Clone 112 AATTCAATAG - 
Clone 113 TTACATTCCG OCT-1, VBP 
Clone 114 TGACGTATCC GATA 
Clone 115 AGTTGCAGCT AP-4 
Clone 116 CTGCTTGCGC - 
Clone 117 ATTAACGG V-MYB 
Clone 118 ATTTAACGG V-MYB 
Clone 119 ATTTAACGG V-MYB 
Clone 120 ATTTAACGG V-MYB 
Clone 121 ATTTAACGG V-MYB 
Clone 122 ATTTAACGG V-MYB 
Clone 123 ATTTAACGG V-MYB 
Clone 124 GTGGTTCACC - 
Clone 125 CAATCGGTGG GFI-1 
Clone 126 CAATCGGTGG GFI-1 
Clone 127 TGAATATGCC OCT -1 
Clone 128 ACGGCGGGCT - 
Clone 129 ACGGCGGGCT - 
Clone 130 TGCTGGGCA - 
Clone 131 TGCTGGGCA - 
Clone 132 ACGGCGGCT - 
Clone 133 TTATTCGTG - 
Clone 134 GGCTTTGTG - 
Clone 135 GTACTTTTG - 
Clone 136 CTGGCGGGG AP-4, SP-1 
Clone 137 CTGGCGGGG AP-4, SP-1 
Clone 138 TTGGATGTG - 
Clone 139 AAGTATAGAT TATA 
Clone 140 GCGGTTCGCG - 
Clone 141 GGCTCATTCC - 
Clone 142 GTACTTTTG - 
Clone 143 ATGGGGGTGA SREBP 
Clone 144 TCGTGCTTGT - 
Clone 145 GGATGGGGT - 
Clone 146 GTACTTTTT - 
Clone 147 TGATATGAT GATA, TCF-II 
Clone 148 CGGCGTAGTG - 
Clone 149 TACTTGTTCC - 




Table 1. Contd. 
 
Clones Nucleotide sequence Target sites 
Clone 150 GGATGGGGTG - 
Clone 151 CCGGCGGGG AP-2 
Clone 152 CAATCGGTGG GFI-1 
Clone 153 TTTGTTGTG VSTY 
Clone 154 GAACCCAAGT - 
Clone 155 GAACCCAAGT - 
Clone 156 GAACCCATTA S8 
Clone 157 GAAGCCATTA CAAT, S8 
Clone 158 TGGCAGAAC NF-1 
Clone 159 ATGTGTTGGG - 
Clone 160 AGTTCTCAT - 
Clone 161 TGGCAGTAC NF-1 
Clone 162 CGGAACTCG - 
Clone 163 GATCACCGGG - 
Clone 164 CGGAACTCG - 
Clone 165 ATTTAACGG V-MYB 
Clone 166 TGCATACTGC OCT-1 
Clone 167 ACGGCGGCT - 
Clone 168 CCGGCGGGG AP-2 
Clone 169 AAGTATAGAT TATA 
Clone 170 CGGAACTCG - 
Clone 171 GATCACCGGG - 
Clone 172 GAAGCCATTA CAAT, S8 
Clone 173 ATTTAACGG V-MYB 
Clone 174 TTAGTGTGTC - 
Clone 175 TTATTGGGT NKX-2.5 
Clone 176 CGTAAGTATG - 
Clone 177 TGCATACTGC OCT-1 
Clone 178 CATGAAAAC - 
Clone 179 GGACAAGCTG AP-4 
Clone 180 TTAGTGTGTC - 
Clone 181 TTAGAGTG - 
Clone 182 TAAGAGTCG - 
Clone 183 TAAGTGTGTC - 
Clone 184 TTATTGGGT NKX-2.5 
Clone 185 TATGAGTCG - 
Clone 186 ATGGGGGTGA SREBP 
Clone 187 CGGAACTCC - 
Clone 188 TAAGA GTCG - 
Clone 189 GAACCCATTA S8 




Identification of similar binding sites in the pool 
 
cis-Regulatory target sequences are known for various 
degrees of variability in the nucleotide bases at different 
positions. It was also observed that many of the known 
sequences isolated  were  different  from  their  canonical  
 






Figure 3. DNAse I Foot printing analysis of candidate clone 
(2). Left lane is the control digestion (without any nuclear 
protein), middle lane is digestion with liver extract and the 
right lane is digestion with heart extract. Protected region is 
shown by a bracket and the cognate sequence is marked by 
blue letters and the unprotected sequences are shown in 
black letters. Protein binding sequences from the vector is 
also marked. (Vector sequences just flanking the core 
sequence were also having the protein binding sites that gave 




counterparts. We therefore tested whether the binding 
sequences identified by DNAse I foot printing also 
occurred in other sequences (unknown category) present 
in the pool of novel sequences. The number of such 
binding sequences showed multiple homologues.    
To further establish the functional correlations of these 
homologous binding sites, elctrophoretic gel mobilityshift-
competition assay was performed using 12-day-old chick 
embryonic heart nuclear extract. Radiolabeled probe was 
prepared from the sequences (ATAGTGTGTT)) 
characterized by foot printing and its relatedness was 
tested by competition with fifty-fold molar excess of 
unlabeled homologous sequences. As shown in Figure 4, 
clone number 2 (ATAGTGTGTT) upon foot printing showed 
a protected region GTGTT. Upon sequence comparison, 
It was found that at least two other sequences (# clone 3 
and # clone 87) also harbored the same sequence and 
two more had similar sequences, clone 181 GAGTG, # 
clone 187 GAGTC) (Table 1). To find their functional 
correlations, a gel mobility shift-competition assay was 
performed using radiolabeled # clone 2 (ATAGTGTGTT) 
as probe and fifty fold molar excess of those sequences 





clone 87 (ATGTGTTGGG) and clone 3 (GTACAGTGTT) 
effectively competed the complex formed by # clone 2, 
sequence. As expected, the other two sequences; clone 
181 (TTAGaGTg) and clone 188 (TAAGaGTcG) which 
harbored variants of GTGTT, only partially competed the 
clone 2 specific complex. These data therefore indicate 
that the same binding protein with different affinities might 




In-silico foot print analysis for novel target site 
(GTGTT) 
 
Following experimental identification of exact target sites 
and their homologous sequences, we also did a 
computational analysis of the entire pool of sequences to 
club them into groups of related sequences and thereby 
determine the exact binding sites (in silico foot printing). 
To that purpose, we used the program Pratt 
(http://bioweb.pasteur.fr/seqanal/motif/meme/Prattwwww)
(Jonassen et al., 1995, 1997) and derived fuzzy sequence 
patterns, which included at least five sequences. It allows 
the discovery of conserved patterns only when they exist.  
We thus identified twenty such patterns (Table 2). As 
expected, some of those derived patterns were either 
corresponding to known transcription factor binding sites 
such as NFAT-1, NF-1, Nkx 2.5 and GATA or those novel 
sites which we have already identified by DNAse I foot 
printing analysis. GTGTT was also found in the analysis 
which further validates our data. It needs to be noted that 
in order to avoid any mutual bias in identifying novel 
sequences, we did the experimental analysis (DNAse I 
foot printing) prior to the computational analysis. These 
data therefore established that the novel target site/s can 
be efficiently used for the identification of conserved 
sequence motifs, which are likely to be the protein 
binding sites (transcription factor binding sites). 
 
 
Promoter analysis for the regulatory target sites 
 
We also searched the eukaryotic promoter database 
(EPD) (http://cmgm.stanford.edu/ help/manual/database/ 
epd.html) for finding the occurrences of a number of 
binding sequences as identified above by DNAse I foot 
printing analysis. Since most of the binding sequences 
identified (by in silico analysis and DNAse I foot printing) 
were relatively small (4 - 6 nucleotides), it was expected 
to have a large number of hits (due to randomness). To 
eliminate the random occurrences, only those, which 
occurred in conjunction with other known binding sites or 
more than once in a promoter were considered.   
It was found that the novel target site, GTGTT, occurs 
in a large variety of promoters including those from 
plants. While a substantial number  of  them  contained  it  
 






Figure 4. Identification of homologous target site for clone 2 (ATAGTGTGTT) in the pool. 
Comparison of the DNA binding properties of homologous sequences of clone 2. Panel A: 
Radiolabeled probe was prepared from clone 2 (ATAGTGTGTT) containing the binding site 
GTGTT. Fifty-fold molar excess of four independent sequences harboring either completely or 
partly homologous sequences (Table 1) were used as competitors. The number on each lane 
represents the sequence number, i.e., 3: GTACAGTGTT, 87: ATGTGTTGGG, 181: TTAGAGTG, 
188: TAAGAGTCG. Sc: Specific competitor (fifty fold molar excess of unlabeled self DNA). Fifty-
fold molar excess of nonspecific (unrelated sequence) competitor (Ns) was also used; Panel B: 




twice, a few contained GTGTT sequence even thrice or 
more (Table 3). Since the relevance of occurrence of 
GTGTT sequence once or twice in a particular promoter 
could not be assessed by such analysis, few other criteria 
to determine whether those sequences are functionally 
important were adopted. 
Regulatory elements are characterized by their 
occurrence in clusters and generally, co-regulated genes 
contain similar regulatory elements. We therefore clustered 
these promoters (genes) based on their functional 
relatedness and then looked for other known regulatory 
sequences immediately neighboring the GTGTT sequence. 
We thus created clusters in various promoters (interlukin, 
endocrine hormone promoters). 
Figure 5 shows the clustering of conserved target sites 
in interlukin promoter. The interspecies sequence conser-
vation of our novel regulatory target sites (GTGTT) was 
also found. Target site was found to be well conserved 




Characterization of binding activity of Novel (GTGTT) 
target site by Southwestern analysis 
 
Since our future objective is the molecular cloning of 
regulatory target site specific proteins, the binding was 
further confirmed by southwestern assay. Southwestern 
blotting was carried out by resolving nuclear extracts 
prepared from chick embryonic  tissues  (heart,  liver  and  
 




Table 2. in-silico foot print analysis for novel target site.  
 




aTGTGTTggg   
atagTGTGTT      
aTGTGTTggg   




atAGTGTGtt    
gtacAGTGTT      
gtagAGTGTT     
ttAGTGTGtc    
TGTTGGctcc 
T-[CG]-T-T-G-
G (24.1729) FP (CTTG) 
 aTCTTGGgct  
atgTGTTGGg     
aTCTTGGgct   




aTAGTGTgtt   
 TAGTCTcact  
 tTAGTCTgc    
 tTAGTGTgtc   
atAGTGTGtt 
A-G-T-[CG]-T-
G (24.1729) ND 
atAGTGTGtt    
ctaAGTCTGt     
ttAGTCTGc     




ATGGGCgtt   
cATGGGGccg   
ggATGGGGt     
ggATGGGGtg    
GAACCCatta 
G-A-A-C-[CT]-
C (24.0745) ND 
cgGAACTCg     
cgGAACTCg     
GAACCCaagt  
GAACCCaagt  




aTACTTTtt    
gTACTTTtg    





brain). The proteins were electro blotted to nitrocellulose 
membrane and probed by radiolabelled novel target site. 













atACTTTTt     
gtACTTTTg     
gtACTTTTt     




aTACTTTtt    
gTACTTTtg    





ataGTGTGTt     
ataGTGTGTt     
gtaGAGTGTt     
tgaGAGTGTc     
ttaGTGTGTc     
ttaTTGGGt 
T-T-G-G-G 
(20.8503) Nkx 2.5 
atcTTGGGct    
atgtgTTGGG       
atcTTGGGct    





tgtgtGTATC       
tgaaGTATCc     




ttTTCTTTca    
aTACTTTtt    
aTACTTTtt    
gTACTTTtg    






attAAGGGGt     
cATGGGGccg   
ggATGGGGt     






atTAAGGGgt    
TAAGAGctag  
TAAGAGcttg  




activity of target site, ATAGTGTGTT (Figure 6). Numbers 















ctACAGTGtc    
gtACAGTGtt    
gtAGAGTGtt    




atgtGTTGGG       
attcGTTGGT       
atgtGTTGGG       




atgtGTTGGG       
gGATGGGgt    
gGATGGGgtg   




aTAGTGTgtt   
aTAGTGTgtt   
gTAGAGTgtt   




aTGGGCGtt    
atctTGGGCT       
aTGGGCGtt    




ataCTTTTT       
ataCTTTTT       
CTGTTTcggc  
gtaCTTTTT       
atagtGTGTT 
G-T-G-T-T 
(20.8503) FP (GTGTT) 
atGTGTTggg   
atagtGTGTT       
atGTGTTggg   
gtacaGTGTT       
gtagaGTGTT       
 
* FP: target site was independently confirmed by foot print 
analysis. ND: Foot printing analysis has not been done. GTGTT 




both panels) are due to the binding of proteins to the 
vector sequences adjoining the core randomized 
sequences. The southwestern assay in stage specific 
and species specific manner was also performed which 
also confirms the fact that the novel regulatory target site  








Characterization of binding activity of novel target 
site by gel mobility shift assay 
 
We further confirmed the binding of our novel target site 
(ATAGTGTGTT) by gel mobility shift assay by using 
nuclear extract from embryonic chicken heart. Gel 
mobility shift assay was done with probe prepared from a 
double stranded synthetic oligonucleotide harboring only 
the core sequence (ATAGTGTGTT) of novel target sites 
(with no flanking sequence). As shown in Figure 7 
binding activity is specific for the novel target sites as 50 




Developmental regulation of novel target site 
 
Finally, the developmental expression of the binding 
activity of novel target site (ATAGTGTGTT) was tested. 
For that, the nuclear extract from various stages of chick 
embryonic heart forming regions was prepared and 
probed with the radiolabeled novel target site. The 
expression was found to be developmentally regulated. It 
was found that its expression was moderate in early 
stages of chick development (4 - 8th day), high in middle 
stages (12 – 16th day) and very less in later stages of 





Eukaryotes are characterized by enormously complex 
genome organization which is decoded by highly co-
ordinated molecular interactions involving multiple 
regulatory modules such as cell signaling cascades, a 
large repertoire of sequence specific DNA binding 
proteins (transcription factors and other related proteins), 
chromatin modifiers and numerous small DNA elements 
located in the regulatory regions of various genes. 
Although tools of cellular and molecular biology have 
enhanced our understanding about various cell signaling 
pathways and mechanisms of transcription, our knowledge 
about the regulatory DNA elements specifying the spatial 
and temporal pattern of gene expression is inadequate. A 
complete catalogue of eukaryotic DNA elements (with 
positional weight matrices) targeted by transcriptional and 
other sequence specific regulators are a major challenge 
to the genome biologists.    
The present study involves primary characterization of 
a library of regulatory DNA elements (<10 base pairs) 
constructed in our laboratory recognized by nuclear 
proteins from embryonic chick heart. Genetic cascades 
regulating cardiac development are highly conserved 
 




Table 3 Compilation of promoters which contain the novel target site GTGTT at least three times or more within 
the first 500 base pairs from the transcription start site. 
 
Name of the gene and species Number of sites in the Proximal promoter (-500) 
a. Ribosomal protein S15, Human 5 
b. Von Willebrand factor, Human 4 
c. Aldolase B, Human 3 
d. TOPK, a mitotic kinase, Human 3 
e. MBLL39, Factor that co-localize with nuclear 3 
f. foci of expanded-repeat transcripts, Human 3 
g. SLC38A2, Interacts with melanin-concentrating hormone, Human 3 
i. SF3B1, Splicing factor, Human 3 
j. BNIP3L, Bcl-2 family protein, Human 3 
k. TGM2, transglutaminase 2, Human 3 
l. PRG1,  Human 3 
m. Human PSMD1, Human 3 
n. DLK1, death associated protein kinase homologue, Human 3 
o. TSFM, Mitochondrial Translation factor, Human 5 
p. Human POLR2C 4 
q. Tenascin, Chicken 3 
r. Vitellogenin II, Chicken 3 
s. SnRATA U2, Mouse 3 
t. SnRATA U1a, Mouse 3 
u. SnRATA U2, Mouse 3 




from Drosophila to human. Therefore, identification and 
characterization of targeted DNA elements involved in 
cardiac development is also relevant in the context of 
understanding the general mechanisms of transcription.   
The first part of this study involved sequence 
characterization of 200 candidate target sites (for 
sequence specific DNA binding proteins) (Table 1 and 
Figure 1). About 50% target sites were represented 
binding sites for known transcription factors, thereby 
indicating that the remaining unique sequences are likely 
targets of yet unknown transcriptional regulators. Due to 
the non-availability of databases for other sequence 
specific DNA binding proteins, verification could not be 
made whether any of those novel sequences represent 
such activities. It thus likely that the present collection 
contains thousands of novel binding sites (but not 
necessarily an equal number of novel binding proteins) 
present in the pool.  
Since the long term objective of this study is to create a 
comprehensive catalogue of regulatory target sites, a 
number of criteria were subsequently imposed for 
assessing the authenticity of those novel sequences. As 
required, majority of the tested sequences showed specific 
binding activities (study done by other researchers in the 
laboratory) thereby establishing that the novel sequences 
are the bonafide targets for gene regulatory proteins.   
Since the candidate target sites were selected from a 
pool of decanucleotide sequences, the protein binding 
sequences they harbored were likely to be restricted to 4  
-10 bases (the minimum length of DNA sequences 
targeted by sequence specific DNA binding proteins are 
four). A number of such sequences were subsequently 
identified by DNAse-I foot printing analysis and as 
expected, their lengths varied from four to eight 
nucleotides (except only two binding sites that spanned 
into the adjoining vector sequence). Foot printing analysis 
performed established the diversity as well as the 
authenticity of these candidate target sequences. In a 
pool of random sequences, the frequency of occurrence 
of any particular sequences would be decreasing with 
increase in length. A tetra nucleotide sequence will thus 
occur once in every 256 bases while a penta-nucleotide 
sequence will occur once in every 1016 bases. It is thus 
expected that among the selected sequences, smaller 
binding sites would occur more frequently than the larger 
sequences (that is, in proportion to their frequency of 
occurrence in the pre-selection pool). In agreement to 
such proposition, we observed that the smaller binding 
sites such as GTGTT had number of homologues (similar 
sequences with variations in one or two nucleotide 
positions) as identified by sequence comparison. Functional 
relatedness among these (similar) sequences was thereby 
 












Figure 6. Characterization of binding activity of novel (GTGTT) target site by 
Southwestern analysis. South western blotting was carried out by resolving nuclear 
extracts prepared from chick embryonic heart (H), brain (B) and liver (L) on SDS-
PAGE. The proteins were electro blotted to nitrocellulose membrane and probed. 
Specific complexes in figure are identified as  .  Number of complexes formed in 
gel (identified by a thick arrow) is due to the binding of proteins to the vector 
sequences adjoining the core sequences as observed in foot print analysis.  
 







Figure 7. Characterization of binding activity of novel target site by gel mobility shift assay. Panel 
A-Gel mobility shift-competition assay was carried out with radiolabeled probe prepared from 
clone 2 monomer (ATAGTGTGTT, only core sequence) and incubated with embryonic chick hear 
extract. Lane 1: Control (no competitor was added.) Lane 2 and 3: 25 and 50 ng self competitor 
respectively (cold oligo) was added in the reaction. Lanes 4 and 5: 25 and 50 ng nonself 
competitor was added in the reaction, respectively; Panel B- quantitation analysis of the binding 






Figure 8. Developmental regulation of novel binding activities. Gel 
mobility shift assay was carried out on radiolabeled probe prepared from 
novel target site (ATAGTGTT). Five micrograms of nuclear extract 
prepared from heart forming regions of day 4, 8, 12 16 and 20 chick 




confirmed by gel mobility shift-competition assay. Thus a 
number of known transcription factor binding sites as well 
as unknown binding sequences (GTGTT) had multiple 






The catalogue of regulatory target sites constructed is 
presumably too large for the experimental determination 
of each binding sites. A computational approach for 
identifying more target sequences (novel) was thus 
developed. Using the program “Pratt” we identified a 
number of frequently (at least five) occurring patterns and 
verified their authenticity by matching them with authentic 
binding sites (either experimentally identified or from 
TRANSFAC data base).  Occurrence of a number of 
known as well as novel target sequences among these 
patterns demonstrates the usefulness of such analysis in 
predicting novel target sequences. We also used another 
parameter, that is, co-occurrence of a novel sequence in 
clusters with other known transcription factor binding 
sites in eukaryotic promoters. Analysis with the GTGTT 
sequence showed that it occurred in clusters with a set of 
known transcription factor binding sites in histone and 
interleukin promoters from multiple species thereby 
indicating its role in regulating interleukin and histone 
gene expression. We further characterize the binding 
activity of novel target site by gel mobility shift assay and 
south western assay which also confirms the heart 
enriched binding activity of candidate target sites. In the 
final study, we tested the concept of differential gene 
expression. For that, we tested the binding activity of our 
novel sequence by using the heart nuclear extract from 
various staged of chick embryonic development. Our data 
clearly shows the context dependent expression of novel 
target site.  
In conclusion we propose a number of possible 
applications: (i) This novel target sites can be directly 
used for cloning the cognate protein; (ii) the cognate 
protein can be expressed and purified; (iii) the targeted 
protein can be extensively characterized; (iv) the informa-
tion can be used for identifying the novel expression 
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